363 related articles for article (PubMed ID: 21482542)
1. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
Huang CY; Lai KY; Hung LF; Wu WL; Liu FC; Ho LJ
Rheumatology (Oxford); 2011 Aug; 50(8):1379-89. PubMed ID: 21482542
[TBL] [Abstract][Full Text] [Related]
2. Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.
El Mabrouk M; Sylvester J; Zafarullah M
Biochim Biophys Acta; 2007 Mar; 1773(3):309-20. PubMed ID: 17208315
[TBL] [Abstract][Full Text] [Related]
3. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes.
Wang X; Li F; Fan C; Wang C; Ruan H
Int J Mol Med; 2011 Apr; 27(4):583-9. PubMed ID: 21305249
[TBL] [Abstract][Full Text] [Related]
4. Leptin modulates the expression of catabolic genes in rat nucleus pulposus cells through the mitogen-activated protein kinase and Janus kinase 2/signal transducer and activator of transcription 3 pathways.
Miao D; Zhang L
Mol Med Rep; 2015 Aug; 12(2):1761-8. PubMed ID: 25892402
[TBL] [Abstract][Full Text] [Related]
5. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
[TBL] [Abstract][Full Text] [Related]
7. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
8. COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro.
Huang CY; Hung LF; Liang CC; Ho LJ
Eur J Clin Invest; 2009 May; 39(5):417-28. PubMed ID: 19371268
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin prevents articular cartilage matrix destruction in human chondrocytes.
Liu J; Cao L; Gao X; Chen Z; Guo S; He Z; Qian Y; Yu Y; Wang G
Biomed Pharmacother; 2018 Feb; 98():651-655. PubMed ID: 29291551
[TBL] [Abstract][Full Text] [Related]
10. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice.
Blaney Davidson EN; Remst DF; Vitters EL; van Beuningen HM; Blom AB; Goumans MJ; van den Berg WB; van der Kraan PM
J Immunol; 2009 Jun; 182(12):7937-45. PubMed ID: 19494318
[TBL] [Abstract][Full Text] [Related]
11. The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes.
Li H; Chen J; Li B; Fang X
Chem Biol Interact; 2020 May; 322():108968. PubMed ID: 32004530
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.
Lim H; Kim HP
Arch Pharm Res; 2011 Jan; 34(1):109-17. PubMed ID: 21468922
[TBL] [Abstract][Full Text] [Related]
13. Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.
Priam S; Bougault C; Houard X; Gosset M; Salvat C; Berenbaum F; Jacques C
Arthritis Rheum; 2013 Jul; 65(7):1831-42. PubMed ID: 23552998
[TBL] [Abstract][Full Text] [Related]
14. Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis.
Hu N; Gong X; Yin S; Li Q; Chen H; Li Y; Li F; Qing L; Yang J; Zhu S; Wang J; Li J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3239-3245. PubMed ID: 31364869
[TBL] [Abstract][Full Text] [Related]
15. Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes.
Rosa SC; Rufino AT; Judas FM; Tenreiro CM; Lopes MC; Mendes AF
J Cell Biochem; 2011 Oct; 112(10):2813-24. PubMed ID: 21608018
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated HS6ST2 in osteoarthritis and Kashin-Beck disease inhibits cell viability and influences expression of the genes relevant to aggrecan metabolism of human chondrocytes.
Wang W; Zhong B; Sun J; Cao J; Tian J; Zhong N; Zhao W; Tian L; Xu P; Guo D; Ju X; Ma W; Li M; Hou W; Lu S
Rheumatology (Oxford); 2011 Dec; 50(12):2176-86. PubMed ID: 21972422
[TBL] [Abstract][Full Text] [Related]
17. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes.
Henrotin YE; Deberg MA; Crielaard JM; Piccardi N; Msika P; Sanchez C
J Rheumatol; 2006 Aug; 33(8):1668-78. PubMed ID: 16832844
[TBL] [Abstract][Full Text] [Related]
18. Selective JAK/STAT3 signalling regulates transcription of colony stimulating factor-2 and -3 in Concanavalin-A-activated mesenchymal stromal cells.
Zgheib A; Pelletier-Bonnier É; Levros LC; Annabi B
Cytokine; 2013 Aug; 63(2):187-93. PubMed ID: 23688618
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes.
Nah SS; Choi IY; Yoo B; Kim YG; Moon HB; Lee CK
FEBS Lett; 2007 May; 581(9):1928-32. PubMed ID: 17434489
[TBL] [Abstract][Full Text] [Related]
20. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.
Kim HA; Cho ML; Choi HY; Yoon CS; Jhun JY; Oh HJ; Kim HY
Arthritis Rheum; 2006 Jul; 54(7):2152-63. PubMed ID: 16802353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]